David Kuter

31PUBLICATIONS
54CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|May 20, 2026
The hunt for a cure: modern medical approaches for immune thrombocytopenia.

|Aug 11, 2025
Evaluating rilzabrutinib in the treatment of immune thrombocytopenia.

David J Kuter, Waleed Ghanima

|Aug 05, 2025
Safety and efficacy of daratumumab in immune thrombocytopenia.

Galina Tsykunova, Pål Andre Holme, Hoa Thi Tuyet Tran

|Mar 16, 2025
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

David J Kuter, Waleed Ghanima, Nichola Cooper

|Jan 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

Nichola Cooper, A J Gerard Jansen, Robert Bird

|Nov 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension.

Nichola Cooper, James B Bussel, Maciej Kaźmierczak

Pageof 6

Frequent Collaborators

5 joint publications

Hanny Al-Samkari

5 joint publications

Waleed Ghanima

3 joint publications

Alexander Röth

3 joint publications

Ahmed Daak